BridgeMD
New treatment option for Septic Cardiomyopathy
Official title The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
ClinicalTrials.gov ID: NCT06898723
What this study is testing
What is Shenfu Injection?
Shenfu Injection is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for septic cardiomyopathy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study focuses on improving heart function in patients with life-threatening blood infections (septic shock). When the body fights severe infections, the heart sometimes struggles to pump blood effectively, which can lead to dangerous complications.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1\. Patients clinically diagnosed with septic shock must meet the diagnostic criteria of Sepsis 3.0;
- 2\. Age ≥ 18 years.
You likely can't join if
- 1\. Pregnant or breastfeeding women;
- 2\. Individuals with a history of allergies or known hypersensitivity to Ginseng and Aconite Injection or its components;
- 3\. Severe underlying diseases that may affect prognosis, including uncontrolled malignant tumors with multiple metastases that are unresectable...
- 4\. Severe cardiac conditions within the last three months, including acute unstable myocardial infarction, dilated cardiomyopathy, acute coronary...
- 5\. Any of the following medical procedures performed within the last three months: any form of cardiac surgery, thoracotomy, external cardiac...
- 6\. Use of Ginseng and Aconite Injection for less than 48 hours;
See the full eligibility criteria
- 1\. Patients clinically diagnosed with septic shock must meet the diagnostic criteria of Sepsis 3.0;
- 2\. Age ≥ 18 years.
- 1\. Pregnant or breastfeeding women;
- 2\. Individuals with a history of allergies or known hypersensitivity to Ginseng and Aconite Injection or its components;
- 3\. Severe underlying diseases that may affect prognosis, including uncontrolled malignant tumors with multiple metastases that are unresectable, hematological disorders, cachexia, persistent active bleeding, severe...
- 4\. Severe cardiac conditions within the last three months, including acute unstable myocardial infarction, dilated cardiomyopathy, acute coronary syndrome, acute or chronic valvular heart disease, and congestive heart...
- 5\. Any of the following medical procedures performed within the last three months: any form of cardiac surgery, thoracotomy, external cardiac compression, defibrillation, direct current cardioversion, or trauma;
- 6\. Use of Ginseng and Aconite Injection for less than 48 hours;
- 7\. Patients expected to die within 48 hours;
- 8\. Patients deemed unsuitable for this study by the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhu, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhu, Anhui, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.